These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7813540)

  • 21. The use of megadose corticosteroids in traumatic optic neuropathy: case studies.
    Orticio LP
    Insight; 2003; 28(2):39-44; quiz 45-6. PubMed ID: 12889281
    [No Abstract]   [Full Text] [Related]  

  • 22. [Bolus methylprednisolone therapy for aplastic anemia: a case report].
    Urabe A; Katsuya H; Miyazono K; Ohta M; Sato H; Nishida J; Hirai H; Kitamura K; Ozawa K; Sato N
    Rinsho Ketsueki; 1984 Jun; 25(6):888-93. PubMed ID: 6481979
    [No Abstract]   [Full Text] [Related]  

  • 23. Pulse methylprednisolone therapy in rheumatoid arthritis: unproved therapy, unjustified therapy, or effective adjunctive treatment?
    Smith MD; Ahern MJ; Roberts-Thomson PJ
    Ann Rheum Dis; 1990 Apr; 49(4):265-7. PubMed ID: 2187419
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum erythropoietin and granulocyte-macrophage-colony stimulating factor levels with megadose methylprednisolone treatment.
    Sayli TR; Ozsoylu S
    Turk J Pediatr; 1996; 38(4):491-5. PubMed ID: 8993179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of patients with myelofibrosis to megadose methylprednisolone.
    Cohn SL
    Clin Pediatr (Phila); 1991 Oct; 30(10):605. PubMed ID: 1934845
    [No Abstract]   [Full Text] [Related]  

  • 26. Failure of a tapering dose of oral methylprednisolone to treat reactions to poison ivy.
    Ives TJ; Tepper RS
    JAMA; 1991 Sep; 266(10):1362. PubMed ID: 1831866
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-surgical management of spinal cord injuries: a review of studies with the glucocorticoid steroid methylprednisolone.
    Hall ED; Braughler JM
    Acta Anaesthesiol Belg; 1987; 38(4):405-9. PubMed ID: 3327343
    [No Abstract]   [Full Text] [Related]  

  • 28. Pulse methylprednisolone therapy for threatening periocular haemangiomas of infancy.
    Delesalle F; Staumont D; Houmany MA; Breviere GM; Piette F
    Acta Derm Venereol; 2006; 86(5):429-32. PubMed ID: 16955189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autosomal malignant osteopetrosis. From diagnosis to therapy.
    Mohn A; Capanna R; Delli Pizzi C; Morgese G; Chiarelli F
    Minerva Pediatr; 2004 Feb; 56(1):115-8. PubMed ID: 15249921
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet Levels of High- and Mega-Dose Methylprednisolone Treatment in Acute Immune Thrombocytopenia.
    Ayçiçek A
    Turk J Haematol; 2015 Jun; 32(2):186-7. PubMed ID: 26316491
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of traumatic optic neuropathy with corticosteroids.
    Spoor TC; Hartel WC; Lensink DB; Wilkinson MJ
    Am J Ophthalmol; 1990 Dec; 110(6):665-9. PubMed ID: 2248332
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Megadose methylprednisolone therapy for Kasabach-Merritt syndrome.
    Ozsoylu S
    J Pediatr; 1996 Dec; 129(6):947-8. PubMed ID: 8969749
    [No Abstract]   [Full Text] [Related]  

  • 33. Intravenous methylprednisolone in minimal change nephrotic syndrome.
    Ponticelli C; Imbasciati E; Case N; Zucchelli P; Cagnoli L; Pasquali S
    Br Med J; 1980 Mar; 280(6215):685. PubMed ID: 7363021
    [No Abstract]   [Full Text] [Related]  

  • 34. The hematopoietic effects of prednisone therapy in four infants with osteopetrosis.
    Reeves JD; Huffer WE; August CS; Hathaway WE; Koerper M; Walters CE
    J Pediatr; 1979 Feb; 94(2):210-4. PubMed ID: 762608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon gamma-1b: new indication. Severe malignant osteopetrosis: too many unknowns.
    Prescrire Int; 2006 Oct; 15(85):179-80. PubMed ID: 17128525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardized dosing tables to reduce errors involving high-dose methylprednisolone for acute spinal cord injury.
    Lesar TS
    Hosp Pharm; 1994 Oct; 29(10):935-6, 938. PubMed ID: 10137851
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylprednisolone pulse therapy by the Tune-Mendoza protocol in a child with severe Henoch-Schönlein nephritis.
    Shin JI; Park JM; Kim JH; Lee JS; Jeong HJ
    Scand J Rheumatol; 2006; 35(2):162-3. PubMed ID: 16641057
    [No Abstract]   [Full Text] [Related]  

  • 38. Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin.
    Albayrak D; Işlek I; Kalaycí AG; Gürses N
    J Pediatr; 1994 Dec; 125(6 Pt 1):1004-7. PubMed ID: 7996346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroids.
    Wright DA; Newburger JW; Baker A; Sundel RP
    J Pediatr; 1996 Jan; 128(1):146-9. PubMed ID: 8551407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Withdrawal of methylprednisolone at the sixth month in renal transplant recipients treated with cyclosporine.
    Cristinelli L; Brunori G; Setti G; Manganoni A; Manganoni AM; Scolari F; Sandrini S; Scaini PS; Savoldi S; Camerini C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2021-3. PubMed ID: 3079069
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.